UNSPSC 51286702: Brodimoprim

This classification denotes a dihydrofolate reductase inhibitor with the molecular formula C13H15BrN4O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier V1YC7T6LLI, chemically known as 2,4-pyrimidinediamine, 5-((4-bromo-3,5-dimethoxyphenyl)methyl)- but more generally known as brodimoprim, which bears US NIH Compound Identifier 68760. European Medicines Agency schedules Brodimoprim in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05898MIG.

UNSPSC 51286702 Brodimoprim is a Commodity code that represents a single active pharmaceutical ingredient used in antimicrobial formulations. The recent state and local procurement activity under this code shows minimal direct solicitation for brodimoprim itself; instead, the tagged opportunities reflect broader pharmaceutical procurement patterns where state and local health agencies source finished pharmaceutical products and medical supplies through piggyback contracts and competitive bidding processes. The issuing bodies are state health departments and county health agencies procuring pharmaceuticals and drug-related medical supplies to support public health and emergency response initiatives, often through multi-year contracts with renewal options and quarterly delivery schedules.

The geographic spread of recent activity centers on Florida and Illinois, with the Illinois Department of Public Health awarding a $2,999,999.11 pharmaceutical warehouse piggyback contract through the MMCAP Infuse consortium to Chartwell Rx LLC for finished antibiotics (Doxycycline Hyclate 100mg and Ciprofloxacin Hydrochloride 500mg tablets) with a 12-month initial term and two one-year renewal options, completed on August 28, 2026 under Invitation for Bid (IFB) 26482DPHPREPDB53392. Seminole County, Florida posted an IFB (60459723LAS) on June 30, 2026 for 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually with quarterly deliveries and a July 26, 2026 response deadline. The mismatch between the code's nominal scope (brodimoprim API) and the solicitations tagged to it (finished pharmaceuticals and medical devices) suggests limited direct procurement activity under this specific Commodity code; state and local health agencies source these goods through cooperative purchasing vehicles and finished-product bidding rather than active pharmaceutical ingredient procurement.